Abstract
Depot antipsychotic drugs, or long-acting injectableantipsychotics (LAIs), have been available since the1960s and were conceived mainly to improve adherenceto treatment in patients with schizophrenia. Even thoughit is known that more than half of the patients withschizophrenia do not properly comply with oral medica-tion treatments
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
